Research > Apply For a Grant
2017 CURE Epilepsy Award
CURE’s investigator-initiated grants program seeks to push the envelope and accelerate promising research leading to disease-modifying breakthroughs for people living with epilepsy. CURE prioritizes highly innovative, risky, paradigm-shifting projects that address CURE’s mission to cure epilepsy, affirming our core belief that the only acceptable final goal is “no seizures, no side-effects.”
CURE: Our mission is to cure epilepsy, transforming and saving millions of lives.
We identify and fund cutting-edge research, challenging scientists
worldwide to collaborate and innovate in pursuit of this goal.
Our commitment is unrelenting.
CURE strongly encourages multidisciplinary, collaborative projects, especially those that are inclusive of investigators and expertise from fields outside of epilepsy.
The following priority areas for 2017 reflect CURE’s focus on advances that have the potential to truly transform and save lives. Prevention and disease modification/elimination are critical goals and consistent with our mission:
- 2017 Priority areas
- Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
- Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy after stroke, tumor, viral infection, etc.*
- Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies
- Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
- Novel research that furthers our understanding of the causes and ultimate elimination of SUDEP
*Due to the exciting launch of our Post-Traumatic Epilepsy Team Science Initiative in collaboration with the Department of Defense, this priority area has been slightly revised to exclude epilepsy as a result of head injury.
- Based on CURE’s current research objectives, lower priority will be given for research in the following areas:
- Research that focuses solely on a comorbid condition without also seeking to address/understand the accompanying epilepsy
- Research that focuses solely on improving localization of the epileptic seizure focus
Eligibility: This award is available to both established and early career investigators*. Researchers who serve on CURE’s Scientific Advisory Council are ineligible to apply for or sponsor a grant for the duration of their term. International applicants are welcome. All materials must be submitted in English.
|2017 FUNDING CYCLE
|Deadline for Receipt of LOI:
||November 16, 2016 - 9pm ET
||April 19, 2017 - 9pm ET
|Full Application Invitations:
||by January 12, 2017
||by May 26, 2017
|Deadline for Receipt of Full Applications:
||February 23, 2017 - 9pm ET
||July 6, 2017 - 9pm ET
|Anticipated Award Announcement:
|Earliest Project Start Date:
See LOI Guidelines
* Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above. Post-doctoral fellows may not apply for this award.